Tiziana Life Sciences Ltd Income Tax Expense Continuing Operations
Tiziana Life Sciences Ltd (TLSA) reported Income Tax Expense Continuing Operations of -$4.88 million for the 12-month period ending 2024-12-31, per its 20-F/A filed 2025-05-08.
Financial Statements › Expense Statement
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2025-05-08
| Period end | Income Tax Expense Continuing Operations 12 month | Income Tax Expense Continuing Operations 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$4.88M 20-F/A · filed 2025-05-08 | |
| 2023-12-31 | $449.00K 20-F/A · filed 2025-05-08 | |
| 2021-12-31 | -$3.24M 20-F · filed 2024-05-10 | -$3.31M 20-F · filed 2022-05-23 |
| 2020-12-31 | -$2.21M 20-F/A · filed 2023-06-13 | |
| 2019-12-31 | -$2.21M 20-F · filed 2023-04-26 | -$689.00K 20-F · filed 2020-06-17 |
| 2018-12-31 | -$1.95M 20-F · filed 2021-05-17 | |
| 2017-12-31 | -$1.91M 20-F · filed 2020-06-17 | |
| 2016-12-31 | -$121.00K 20-F · filed 2019-04-04 |